Department of Health website

Skip to Main Content
Sitemap

Interim Guidelines on COVID-19 Referral Hospitals
Interim Guidelines on the Administration and Management of COVID-19 Vaccine Booster/ Additional Doses to Priority Group A2: Senior Citizen ages 60 years old and above and Priority A3: Adults with Comorbidities
Interim Guidelines on Health Care Provider Networks during the COVID-19 Pandemic
Implementing Guidelines on the Grant of COVID-19 Sickness and Death Compensation to Eligible Public and Private Health Care Workers (HCWs) and Non-HCWs for FY 2022
Interim Guidelines on the Operations of Converted Public & Private Spaces into Temp. Treatment & Monitoring Facilities for COVID-19
Amendment to Department Memorandum No. 2020-0345 dated August 10, 2020 entitled "Updated Suggested Retail Price (SRPs) for Emergency Essential Medicines and Medical Devices Due to the Coronavirus Disease 2019 (COVID-19) Health Event"
Price Freeze of Essential Emergency Medicines due to the 2019-nCoV ARD
Price Range for COVID-19 Reverse Transcription-Polymerase Reaction (RT-PCR) Testing
Use of World Health Organization Interim Guidelines for Health Workers Exposure Risk Assessment and Management in the Context of COVID-19 Virus
Continuity of Operations of Private COVID-19 Testing Laboratories during the Observance of the Holy Week
Interim Guidelines for the Provision of Transport Vehicles to Health Workers and Health Facility Staff Under the Expanded Community Quarantine
Amendment to DM No. 2021-0492: Interim Guidelines on the Administration and Management of COVID-19 Vaccine Booster/Additional Doses to Priority Group A2: Senior Citizens ages 60 years old & above and Priority Group A3...
Revised Interim Guidelines on Expanded Testing for COVID-19
Interim Operational Guidelines on the Administration of Additional Doses of Pfizer-BioNTech COVID-19 Vaccine to Immunocompromised Pediatric A3 ages 12 to 17 Years Old
Updated Guidelines on Contact Tracing of Close Contacts of Confirmed Coronavirus Disease (COVID-19) Cases
Amendment to Department Memorandum No. 2020-0258 entitled Updated Interim Guidelines on Expanded Testing for COVID-19
Interim Guidelines on Overseas Filipinos Repatriates due to 2019-nCoV ARD
Amendment to Department Memorandum No. 2020-0270 entitled "Guidelines in the Certification of LIGTAS COVID Community Isolation Units"
Reiteration of the Price Freeze of Essential Emergency Medicines and Medical Devices due to the Coronavirus Disease 2019 (COVID-19) Health Event
Interim Guidelines on Rapid Antigen Test Reporting for the NCR Plus Bubble
Further Clarification on the National Deployment and Vaccination Plan for COVID-19 Vaccines and Additional Guidelines for Sinovac Implementation
Adoption of POGS, PPS, PIDSOG, PSMFM, PSNbM, and PIDSP Clinical Approach to the Management of COVID-19 in Pregnancy and the Newborn
Advisory on COVID-19 Protocols for Quarantine and Isolation
Revised Interim Guidelines on the Mass Repatriation and Mandatory Quarantine of Overseas Filipinos (OF) Working in Cruise Ships during the Coronavirus Disease 2019 (COVID-19) Pandemic
Supplemental guidelines to the DOH-DBM JAO No. 2022-0001 for the processing of COVID-19 sickness and death compensation claims for eligible public and private health workers for calendar years 2020 and 2021
Interim Guidelines on Enhancing the Infection Prevention and Control Measures through Engineering and Environmental Controls in All Health Facilities and Temporary Treatment and Monitoring Facilities during the COVID-19 Pandemic
Guidelines on Proper Use and Promotion of Active Transport During and After COVID-19 Pandemic
Interim Guidelines on 2019-nCoV ARD Contact Tracing
Interim Guidelines on the Conduct of COVID-19 Pooled Testing
Off-label Use of Antivirals and Antimalarials for the Clinical Management of COVID-19

Pages